| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Mrz―05 |
High-resolution short-term prediction of the COVID-19 epidemic based on spatial-temporal model modified by historical meteorological data |
Bin Chen, Ruming Chen, Lin Zhao, Yuxiang Ren, Li Zhang, Yingjie Zhao, et al. (+3) Xinbo Lian, Wei Yan, Shuoyuan Gao |
| 2 |
[GO] |
2024―Feb―08 |
Noteworthy impacts of COVID-19 pandemic on cancer screening: a systematic review |
Huilin Wang, Min Yang, Wei Xiong, Quan Wang, Bobo Zheng, Yang Bai, et al. (+6) Kaiyong Zou, Jibin Li, Jiansong Ren, Wanqing Chen, Jingbo Zhai, Jiang Li |
| 3 |
[GO] |
2023―Dez―09 |
COVID-19 transmission and control in land public transport: A literature review |
Qiqi Luo, Wenbing Liu, Jiayuan Liao, Zhongli Gu, Xiaodan Fan, Zhiwen Luo, et al. (+3) Xuelin Zhang, Jian Hang, Cuiyun Ou |
| 4 |
[GO] |
2023―Sep―10 |
Development of the second version of the Global Prediction System for Epidemiological Pandemic |
Jianping Huang, Li Zhang, Bin Chen, Xiaoyue Liu, Wei Yan, Yingjie Zhao, et al. (+6) Siyu Chen, Xinbo Lian, Chuwei Liu, Rui Wang, Shuoyuan Gao, Danfeng Wang |
| 5 |
[GO] |
2023―Mai―07 |
Dynamic and classifier-based model SARS-CoV-2 Omicron spillover risk assessment in China |
Hongjie Wei, Jia Rui, Yunkang Zhao, Huimin Qu, Jing Wang, Guzainuer Abudurusuli, et al. (+6) Qiuping Chen, Zeyu Zhao, Wentao Song, Yao Wang, Roger Frutos, Tianmu Chen |
| 6 |
[GO] |
2023―Mrz―14 |
What can we learn from the 2008 financial crisis for global power decarbonization after COVID-19? |
Pengfei Zhang, Xu Zhao, Laixiang Sun, Jian Zuo, Wendong Wei, Xi Liu, et al. (+6) Xu Peng, Yuli Shan, Shuping Li, Liming Ge, Kuishuang Feng, Jiashuo Li |
| 7 |
[GO] |
2022―Jul―05 |
Quantifying the impacts of COVID-19 on Sustainable Development Goals using machine learning models |
Chenyang Shuai, Bu Zhao, Xi Chen, Jianguo Liu, Chunmiao Zheng, Shen Qu, et al. (+2) Jian-Ping Zou, Ming Xu |
| 8 |
[GO] |
2022―Jun―19 |
Evaluation of COVID-19 outbreak prevention and control in Beijing using the emergency management theory |
Yu Wu, Jue Liu, Min Liu |
| 9 |
[GO] |
2022―Mai―17 |
The Impacts of Gradually Terminating Nonpharmaceutical Interventions for SARS-CoV-2: A Mathematical Modelling Analysis |
Bin Wu, Yuetian Yu, Xinglin Feng |
| 10 |
[GO] |
2022―Mai―13 |
Variability Scaling and Capacity Planning in Covid-19 Pandemic |
L. Jeff Hong, Guangwu Liu, Jun Luo, Jingui Xie |
| 11 |
[GO] |
2022―Apr―22 |
Assessing the spread risk of COVID-19 associated with multi-mode transportation networks in China |
Xiao-Ke Xu, Xiao Fan Liu, Lin Wang, Ye Wu, Xin Lu, Xianwen Wang, Sen Pei |
| 12 |
[GO] |
2022―Mrz―12 |
The blood-brain barrier in health, neurological diseases, and COVID-19 |
Jianan Chen, Rongbang Tan, Yuqian Mo, Jingjing Zhang |
| 13 |
[GO] |
2022―Mrz―03 |
CEBIT Screening for Inhibitors of the Interaction between SARS-CoV-2 Spike and ACE2 |
Gaofeng Pei, Weifan Xu, Jun Lan, Xinquan Wang, Pilong Li |
| 14 |
[GO] |
2022―Jan―30 |
A commentary of “Type I Interferon Deficiency Can Lead to Severe COVID-19” in 10 remarkable discoveries from 2020 in Nature |
Xiangming Fang |
| 15 |
[GO] |
2021―Mrz―07 |
Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice |
Airu Zhu, Zhao Chen, Yanqun Wang, Qiuhui Zeng, Jing Sun, Zhen Zhuang, et al. (+4) Fang Li, Jingxian Zhao, Jincun Zhao, Nanshan Zhong |
| 16 |
[GO] |
2021―Feb―26 |
Immune defenses against coronavirus disease |
Li Bai, Zhigang Tian |
| 17 |
[GO] |
2021―Feb―18 |
Immune profiles of a COVID-19 adolescent with mild symptoms and anti-viral antibody deficiency |
Yang-dian Lai, Ying-ying Chen, Ji-ping Sun, Yun Ling, Jie Xu, Youqiong Ye, et al. (+4) Lei Shen, Hong-zhou Lu, Bing Su, Ying Wang |
| 18 |
[GO] |
2021―Feb―06 |
Insights into biological therapeutic strategies for COVID-19 |
Xiaolong Tian, Cheng Li, Yanling Wu, Tianlei Ying |
| 19 |
[GO] |
2021―Feb―01 |
Drug Discovery and Development Targeting the Life Cycle of SARS-CoV-2 |
Haixia Su, Yechun Xu, Hualiang Jiang |
| 20 |
[GO] |
2021―Jan―26 |
Prognostic Nomogram on Admission Predicting Progression for Patients with Nonsevere COVID-19 |
Zhi Wang, Bin-Yan Zhong, Hui Dai, Qiu-Zhen Xu, Wei-Bin Yang, Xin Zhang, et al. (+8) Chuan-Jun Xu, Jin-Er Shu, Biao Shi, Chu-Hui Zeng, Cheng Li, Jian-Song Ji, Yong-Gang Li, Gao-Jun Teng |
| 21 |
[GO] |
2021―Jan―26 |
Current Progress and Challenges in the Design and Development of a Successful COVID-19 Vaccine |
Tingting Li, Tianying Zhang, Ying Gu, Shaowei Li, Ningshao Xia |
| 22 |
[GO] |
2021―Jan―22 |
Realization of Humoral Immunity against SARS-CoV-2 infections |
Yong Lin, Zhenyu Zhao, Jiaxin Zheng, Jia Liu, Ailong Huang |
| 23 |
[GO] |
2021―Jan―22 |
SARS-CoV-2 virus: vaccines in development |
Qingrui Huang, Jinghua Yan |
|
